U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06833788) titled 'Treatment of Anaemia After Caesarean with Intravenous Versus Oral Iron and Postpartum Depression' on Feb. 13.
Brief Summary: The objectif of the IRON-DEP Study is to assess the efficacy of intravenous (IV) versus oral iron treatment on the prevalence of postpartum depression (PPD) in women with moderate iron deficiency anemia after caesarean delivery.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Postpartum Depression (PPD)
Intervention:
DRUG: Ferric carboxymaltose IV
Single dose of Ferric carboxymaltose 1000 mg (20mL) IV infusion (20ml vial of 1000mg iron or two 10ml vials of 500mg)
DRUG: TIMOFEROL(R)...